Compared with the whole cohort and non-DM population, PCSK9 acquired the highest sensitivity (0.674), specificity (0.597) and overall accuracy (AUC: 0.634, Youden index: 0.271) for predicting MACE in DM patients. Here, PCSK9 is linked to diabetes mellitus.